Catalyst Wire Dossier Catalyst Wire Dossier

H5N1 Subunit Influenza Virus Vaccine

Influenza vaccine, H5N1 subunit · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H5N1 Subunit Influenza Virus Vaccine, covering 2019-04-04 to 2019-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age [Phase 3]

See pricing